ArticleDermatology and therapy2018

Effect of Prior Biologic Use on Cost-Effectiveness of Brodalumab vs. Ustekinumab for Treatment of Moderate-to-Severe Psoriasis in the United States.

Steven R Feldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.